The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Hypercalcemia of Malignancy as Oncologic Emergency

Rapid recognition and stepwise treatment of life-threatening tumor-induced hypercalcemia

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Hypercalcemia of Malignancy as Oncologic Emergency?

Hypercalcemia of malignancy occurs in twenty to thirty percent of patients with advanced cancer and signals a poor prognosis. The four mechanistic groups include humoral hypercalcemia driven by parathyroid hormone-related peptide, osteolytic metastasis with local cytokines, calcitriol-mediated lymphoma hypercalcemia, and rare ectopic true parathyroid hormone secretion.

Symptoms scale with calcium level and rate of rise and include polyuria, dehydration, constipation, fatigue, confusion, and coma. The diagnostic work-up confirms hypercalcemia with corrected total or ionized calcium and identifies the mechanism with parathyroid hormone, parathyroid hormone-related peptide, twenty-five hydroxyvitamin D, and calcitriol levels.

Treatment begins with vigorous isotonic saline at two hundred to three hundred milliliters per hour to restore intravascular volume and promote calciuric urinary loss. Calcitonin lowers calcium within four to six hours and bridges to zoledronic acid or denosumab, which provide sustained control. Hemodialysis is used for severe cardiac or renal compromise.

Symptoms

Polyuria and severe dehydration
Confusion or impaired consciousness
Constipation and abdominal discomfort
Bone pain and weakness
Cardiac arrhythmia in severe cases

Risk Factors

Squamous cell carcinoma of lung or head and neck
Multiple myeloma with osteolytic lesions
Metastatic breast cancer with bone disease
T-cell lymphoma with calcitriol production
Renal cell carcinoma with bone metastasis

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When confusion appears in a cancer patient
  • When polyuria and dehydration develop
  • When unexplained bone pain worsens
  • When constipation does not respond to laxatives
  • When cardiac symptoms or arrhythmia appears

Treatment Methods

01
Aggressive isotonic saline rehydration
02
Subcutaneous calcitonin for rapid calcium reduction
03
Intravenous zoledronic acid or pamidronate
04
Subcutaneous denosumab for refractory or renal cases
05
Glucocorticoids for calcitriol-mediated hypercalcemia
06
Hemodialysis for severe compromise
07
Treatment of underlying malignancy

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.